EVALUATION OF CENTRAL ASIAN AND REGIONAL VARIETIES OF MUMIJO ON HEMOSTATIC DYNAMICS AND WATER–ELECTROLYTE EXCRETION

Authors

  • Boltabaeva Dilbarkhon Fayzirakhmanovna Senior Teacher of Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. Author

Keywords:

Mumijo; Shilajit; Anticoagulant; Fibrinolysis; Diuresis; Natriuresis; Hemostasis

Abstract

Mumijo (Shilajit) is a natural herbo-mineral substance valued in traditional medicine for its rejuvenating and adaptogenic properties. This study evaluated the anticoagulant, fibrinolytic, and diuretic actions of various regional types of mumijo. In vitro and in vivo experimental protocols were conducted using rat, dog, and rabbit models to assess blood coagulation dynamics (via Lee-White clotting assays and thrombelastography) and renal function following treatment with Alai, Khamzaabad, Afghan, Indian, Chinese, and Transbaikal mumijo. Afghan, Alai, Indian, and Transbaikal varieties demonstrated significant, dose-dependent anticoagulant activity. In dogs, oral Alai mumijo (25 mg/kg) markedly prolonged blood clotting time (>900 s vs. 354 s baseline), recalcification time (149 s vs. 94 s), and thrombin time (72 s vs. 13 s), while increasing heparin tolerance and fibrinolytic activity without altering Factor V, Factor VII+X, or total protein levels. Chinese mumijo exhibited minimal hemostatic effect. Intravenous Khamzaabad mumijo (1–50 mg/kg) induced dose-dependent diuresis and natriuresis by reducing renal tubular reabsorption. Regional Central Asian, Afghan, Indian, and Transbaikal mumijo function as effective natural modulators of blood coagulation, clot degradation, and fluid-electrolyte balance.

References

1.Velmurugan, C., et al. Evaluation of safety profile of black shilajit after 91 days repeated administration in rats. Asian Pacific Journal of Tropical Biomedicine, 2012, 2(3), 210-214.

2.Joukar, S., et al. Cardioprotective Effect of Mumie (Shilajit) on Experimentally Induced Myocardial Injury. Cardiovascular Toxicology, 2014, 14, 214-221.

3.Aiello, A., et al. Mumijo Traditional Medicine: Fossil Deposits from Antarctica (Chemical Composition and Beneficial Bioactivity). Evidence-Based Complementary and Alternative Medicine, 2011, 2011, Article ID 738131.

4.Wilson, E., et al. Review on shilajit used in traditional Indian medicine. Journal of Ethnopharmacology, 2011, 136, 1-9.

5.Schepetkin, I. A., et al. Medical Drugs From Humus Matter: Focus on Mumie. Drug Development Research, 2002, 57, 140-159.

6.Agarwal, S. P., et al. Shilajit: A Review. Phytotherapy Research, 2007, 21, 401-405.

7.Schepetkin, I. A., et al. Characterization and Biological Activities of Humic Substances from Mumie. Journal of Agricultural and Food Chemistry, 2003, 51(18), 5245-5254.

8.Barouji, S. R., et al. Health Beneficial Effects of Moomiaii in Traditional Medicine. Galen Medical Journal, 2020, 9, e1743.

9.Tripathi, Y. B., et al. Antilipid Peroxidative Property of Shilajit. Phytotherapy Research, 1996, 10, 269-270.

10.Ghosal, S., et al. Effects of Shilajit and its active constituents on learning and memory in rats. Phytotherapy Research, 1993, 7, 29-34.

11.Schliebs, R., et al. Systemic Administration of Defined Extracts from Withania Somnifera (Indian Ginseng) and Shilajit Differentially Affects Cholinergic But Not Glutamatergic and GABAergic Markers in Rat Brain. Neurochemistry International, 1997, 30(2), 181-190.

12.Ghosal, S. Chemistry of shilajit, an immunomodulatory Ayurvedic rasayan. Pure and Applied Chemistry, 1990, 62(7), 1285-1288.

13.Bhattacharya, S. K., & Ghosal, S. Effect of Shilajit on Rat Brain Monoamines. Phytotherapy Research, 1992, 6, 163-164.

14.Ding, R., et al. Mechanisms of generation and exudation of Tibetan medicine Shilajit (Zhaxun). Chinese Medicine, 2020, 15, 65.

15.Carrasco-Gallardo, C., et al. Shilajit: A Natural Phytocomplex with Potential Procognitive Activity. International Journal of Alzheimer's Disease, 2012, 2012, Article ID 674142.

16.Kloskowski, T., et al. Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment. Scientific Reports, 2021, 11, Article ID 10.1038/s41598-021-01135-2.

17.Bhattacharya, S. K., et al. Effects of Shilajit on biogenic free radicals. Phytotherapy Research, 1995, 9, 56-59.

18.Kanikkannan, N., et al. Shilajit-induced potentiation of the hypoglycemic action of insulin and inhibition of streptozotocin induced diabetes in rats. Phytotherapy Research, 1994, 9, 478-481.

19.Stavropoulos, K., et al. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome. Gynecological Endocrinology, 2018, 34, 490-494.

20.Kaur, S., et al. Parasympathomimetic Effect of Shilajit Accounts for Relaxation of Rat Corpus Cavernosum. American Journal of Men's Health, 2013, 7(2), 119-127.

21.Mamadaliev, S. I., & Ibragimova, N. M. (2024). The effect of Alai mumiyo on bleeding time and blood loss in rats. Re-Health Journal, (4)24, 39.

Downloads

Published

2026-10-16